TG BIOTECH means Target Generation Biotechnology, which addresses a large and growing demand for accelerating the discovery and development of new pharmaceuticals. TG Biotech¡¯s technology platform provides generation and validation of disease-relevant drug targets and lead compounds.
The company has several genomic targets for metabolic diseases such as obesity, hyperlipidemia, fatty liver, arthritis and diabetes.
 
 TG Biotech Co.,Ltd.
  March 20, 2000
  Tae-Lin Huh, Ph.D (CEO)
  (Professor of Kyungpook National University)
  11(5 Ph.D., 4 MS, 1BS and 1 accountant)
  1.8 Billion Won (1.5 million US Dollars)
  Generation of drug targets using functional genomics
  Screening and validation of drug candidates
  RM 507 Techno B/D, Kyungpook National University
  Daegu 702-701, KOREA
  TEL: +82 53 953 0833    FAX: +82 53 953 0834
  Dong-A Phamaceutical Co., Ltd.
  SK Corp.
  Seoulin Bioscience Co., Ltd.
 

copyrights¨Ï2002 TGBiotech Corp. all rights reserved. contact us webmaster@tgbio.com